UK-headquartered ECO Animal Health is to begin development of a live attenuated Mycoplasmasynoviae vaccine for poultry after signing a second agreement with the University of Georgia.
It follows a similar arrangement between the university and ECO Animal Health for potential vaccines in the field of Mycoplasma gallisepticum.
Researchers at the university have concluded preliminary proof-of-concept for both efficacy and safety for the new vaccine.
Peter Lawrence, Non-Executive Chairman of ECO Animal Health Group plc said, “Mycoplasmasynoviae is a bacterium that affects predominately commercial layers and breeding birds worldwide resulting in a 5%-10% loss in egg production and lower egg quality in affected flocks.”
UGA Professor Naola Ferguson-Noel, a researcher in the Poultry Diagnostic & Research Center said, “We look forward to working with ECO Animal Health to help further develop this Mycoplasma synoviae vaccine into an approved product.”
Notifications
Your Privacy Matters
It's your legal right to choose which information a website may store and have access to. With your permission, we and our third-party partners (20) store and/or access information on a device, such as unique identifiers in cookies and browsing data to collect and process personal data.
We and our partners do the following data processing:
Store and/or access information on a device, Advertising based on limited data and advertising measurement, Personalised content, content measurement, audience research, and services development
If you accept any or all of these, you will have agreed to this website's use of cookies for these purposes. You may also choose to refuse consent, but certain personalized features of the site won't be available to you.